The use of Dopram as a respiratory stimulant following Immobilon in the pony.
Abstract: The effects of the analeptic agent, Dopram (doxapram hydrochloride) were investigated in 2 ponies during Immobilon - induced neuroleptanalgesia. Although Dopram was demonstrated to exert a degree of respiratory stimulation, this was concluded to provide no overall advantage. The etorphine-induced hypoxic hypoxia was only partially reversed, and there was additional cardiovascular stimulation, in contrast to the previously reported tendency for arterial blood pressure to return towards conscious control values during the course of action of Immobilon.
Publication Date: 1976-10-01 PubMed ID: 976233DOI: 10.1111/j.2042-3306.1976.tb03334.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigated the effects of Dopram, a respiratory stimulant, on ponies following neuroleptanalgesia induced by Immobilon. It concluded that Dopram offered no overall advantages as it only partially reversed hypoxic hypoxia and caused additional cardiovascular stimulation.
Research Objective and Methodology
- This research aimed to study the effects of the analeptic (stimulating) agent Dopram, specifically doxapram hydrochloride, on ponies following the use of Immobilon, a drug utilized in inducing neuroleptanalgesia – a state of analgesia (relief from pain) and tranquilization.
- The experiment was conducted on two ponies where they were first subjected to Immobilon-induced neuroleptanalgesia and later treated with Dopram.
Research Findings
- The research showed that Dopram did stimulate respiratory function to a certain degree in the ponies, but this was not found to offer any major benefits.
- The ponies, as anticipated, experienced etorphine-induced hypoxic hypoxia (a form of hypoxia where low oxygen in the blood leads to low tissue oxygen levels) due to Immobilon. But the use of Dopram only reversed this condition partially, therefore, didn’t fully address the issue.
- The additional finding was related to cardiovascular stimulation. Dopram was found to induce unexpected cardiovascular stimulation. This result is noteworthy because prior studies have shown arterial blood pressure tends to return to normal, conscious control values after the administration of Immobilon. So, the effect of Dopram on causing further cardiovascular stimulation was in sharp contrast to the known properties of Immobilon.
Conclusion
- The experiment demonstrated that the use of Dopram following Immobilon-induced neuroleptanalgesia in ponies did not provide overall advantage.
- While Dopram showed a certain degree of respiratory stimulus, it was unable to fully reverse hypoxic hypoxia. Furthermore, the introduction of an unexpected cardiovascular stimulation raised flags about its utility in this context.
Cite This Article
APA
Hillidge CJ.
(1976).
The use of Dopram as a respiratory stimulant following Immobilon in the pony.
Equine Vet J, 8(4), 173-175.
https://doi.org/10.1111/j.2042-3306.1976.tb03334.x Publication
Researcher Affiliations
MeSH Terms
- Acepromazine
- Animals
- Doxapram / pharmacology
- Etorphine
- Female
- Horses
- Morphinans
- Neuroleptanalgesia / veterinary
- Respiration / drug effects
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists